Knowledge, firm boundaries, and innovation: Mitigating the incumbent's curse during radical technological change - Roy - 2016 - Strategic Management Journal - Wiley Online Library
3 Beaten-Down Biotech Stocks That Could Bounce Back in 2019 | The Motley Fool
Oncotelic | LinkedIn
A New Drug on the Horizon for HER2 Breast Cancer Patients | Avise Analytics
Company Celcuity News, Employees and Funding Information, Minneapolis, MN
What Type Of Shareholders Own The Most Number of Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares?
Puma Biotechnology's (NASDAQ:PBYI) investors will be pleased with their decent 96% return over the last year
Is Puma Biotechnology, Inc. (NASDAQ:PBYI) Popular Amongst Insiders?
A New Drug on the Horizon for HER2 Breast Cancer Patients | Avise Analytics
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting
Puma Biotechnology Surging
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Puma Biotechnology Inc
Maximo Nougues email address & phone number | Puma Biotechnology, Inc. Chief Financial Officer contact information - RocketReach
Puma Biotechnology Third Quarter 2022 Earnings: Beats Expectations
Puma Biotech (PBYI) Q3 Earnings Top, Nerlynx Sales View Up
A New Drug on the Horizon for HER2 Breast Cancer Patients | Avise Analytics
Biotech Drop: Neither A Bubble-Burst Nor A Growth-Warning
Former Puma Biotech executive gets U.S. prison term for insider trading
PBYI - Puma Biotechnology, Inc. Stock Price and Quote
PBYI Stock Forecast, Price & News (Puma Biotechnology)
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Maximo Nougues email address & phone number | Puma Biotechnology, Inc. Chief Financial Officer contact information - RocketReach
Is Puma Biotechnology (NASDAQ:PBYI) Using Debt Sensibly?
Chinese retail investors throw global commodities into a tailspin | Financial Times
